Master Clinical Specification Matrix | Ethicon Coated VICRYL Polyglactin 910 Braided Suture Portfolio

Expires 10-31-2029

Ethicon Coated VICRYL is a premium, sterile, synthetic absorbable surgical suture precision-woven from a co-polymer composed of 90 percent glycolide and 10 percent L-lactide (polyglactin 910) and uniformly coated with a micro-thin, lubricious blend of caprolactone/glycolide copolymer and calcium stearate. This advanced structural coating reduces dynamic micro-frictional tissue drag and prevents premature knot-snagging, allowing braided multi-throw configurations to slide smoothly into place and lock down flat. Available in both high-contrast dyed violet (for deep field visualization) and undyed clear variations across a comprehensive matrix of USP sizing gauges, Coated Vicryl delivers critical, reliable wound support during the crucial mid-term healing window—maintaining roughly 75 percent active tensile strength at 2 weeks post-op and 50 percent at 3 weeks—before undergoing predictable, progressive degradation via in vivo chemical hydrolysis to achieve complete material mass absorption between 56 and 70 days post-implantation with minimal localized tissue reaction.

Standard Technical Specifications Matrix (Vicryl Portfolio)

• Manufacturer: Ethicon, Inc. (Johnson & Johnson MedTech Division)

• Product Brand Family: Coated VICRYL Polyglactin 910 Suture Portfolio

• Suture Material Composition: Polyglactin 910 Co-Polymer (90% glycolide, 10% L-lactide)

• Strand Structural Construction: Braided Fiber Matrix uniformly coated with polycaprolate and calcium stearate lubricant

• Standard Packaging Configuration: Box containing 36 sterile individual suture packets (H-box distribution unit)

• Absorption Profile Cycle: Degrades reliably via in vivo chemical hydrolysis, resulting in complete mass absorption within 56 to 70 days post-implantation